Retransfusion or Not of Cardiotomy Blood

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
Epistemonikos ID: 634b711bc30f06e90705684828c5d506ad39f2d9
First added on: May 07, 2024